Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comDescription:
Open-label, multicenter, uncontrolled and non-randomized study comparing 18F-FDG PET-Scan and diffusion MRI in the assessment of the early therapeutic response of Diffuse Large B-Cell Lymphoma.
Sponsor:
Centre Antoine Lacassagne
Contacts:
Lauris GASTAUD, Drlauris.gastaud@nice.unicancer.fr
+33492031047
Antoine THYSS, Prantoine.thyss@nice.unicancer.fr
+33492031497
Government Study Link:
NCT03121456 - Click here to see study onClinicalTrials.gov
Help us improve your experience